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Abstract 
Review on Vascular tumors of bones, with data on 
clinics, and the genes involved. Vascular tumors of 
bone spans a spectrum with on one side the overtly 
benign lesions consisting of the haemangiomas and 
on the other side the frankly malignant lesions 
consisting of the angiosarcomas. In between there 
are the intermediate locally aggressive epithelioid 
haemangiomas and the low grade malignant 
epithelioid hemangioendotheliomas. Recently 
translocations and specific mutations have been 
identified to aid the classification of many entities in 
the spectrum of vascular bone tumors. 
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Identity 
Note 
In the spectrum of vascular tumors, ranging from 
benign to frankly malignant, the benign vascular 
lesions of bone are relatively common and occur 
most frequently as an asymptomatic incidental 
finding in the skull or spine. Primary malignant 
vascular tumors of bone are rare. They represent less 
than 1% of primary malignant bone tumors reported 
by the Netherlands Committee on Bone Tumors and 
0,5% of those registered at the Mayo Clinic. 
Clinically they are extremely aggressive and have a 
very poor prognosis. Survival rates are unknown. 
Phylum 
Bones:Vascular tumors 
Classification 
Over the years, the terminology and classification of 
vascular tumors of bone has been highly 
controversial and in literature a great variety of 
names has been proposed. Illustrating this are cases 
described in literature as haemangioendothelioma of 
bone, which probably represents epithelioid 
haemangioma. With the identification of different 
mutations and translocations, specific to the different 
vascular tumors, most of the controversy has been 
resolved. 
The large variety of histological features of vascular 
tumors of bone suggests that it should be regarded as 
a spectrum with on one side the overtly benign 
lesions consisting of the haemangiomas and on the 
other side the frankly malignant lesions consisting of 
the angiosarcomas. In between there are the 
intermediate locally aggressive epithelioid 
haemangiomas and the low grade malignant 
epithelioid hemangioendotheliomas. Recently 
translocations and specific mutations have been 
identified to aid the classification of many entities in 
the spectrum of vascular bone tumors. For the 
haemangiomas VEGFR mutations have been 
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identified, and in epithelioid haemangioma fusion 
genes involving FOS and FOSB with different 
fusion partners have been identified. For epithelioid 
haemangioendothelioma WWTR1/CAMTA1-, and 
in a specific subset YAP/TFE3 fusions are identified 
and in angiosarcoma PTPRB, PLCG1, CIC, KDR, 
and FLT4 mutations and MYC amplifications have 
been found. 
 
Schematic representation of histological spectrum of vascular tumors of bone. 
 
Classification 
Today, the most accepted classification of vascular 
tumors of bone is the 2013 WHO classification: 
 Haemangioma and related lesions 
 Epithelioid haemangioma 
 Epithelioid 
haemangioendothelioma 
 Angiosarcoma 
Clinics and pathology 
Disease 
Haemangioma and related lesions 
Note 
Multiple lesions are defined as (haem)angiomatosis. 
Phenotype / cell stem origin 
Endothelial cell 
Epidemiology 
Haemangiomas are detected relatively common at 
autopsy with no clinical implications. 
Clinics 
In general asymptomatic. 
Cytogenetics 
No cytogenetic investigations reported. 
 
Prognosis 
Haemangiomas have a good prognosis and low 
recurrence rate. 
 
When primary Angiosarcoma of bone exhibits more 
than 3 mitosis per 10 HPF with prominent nucleolus 
and fewer than five eosinophilic granulocytes per 10 
HPF they will likely have a worse prognosis. 
Disease 
Epithelioid haemangioma 
Epidemiology 
Extremely rare. 
Clinics 
Pain localized to the involved anatomical site. 
Cytogenetics 
Fusions involving FOS with different fusion partners 
have been found (t(1;14)(q22;q24) FOS/LMNA; 
t(3;14)(q25;q24) FOS/MBNL1; t(10;14)(p13;q24) 
FOS/VIM). Atypical cases carry  
ZFP36-FOSB fusions (t(19;19)(q13;q13) 
ZFP36/FOSB). 
Prognosis 
Locally aggressive, can be multifocal, and can 
metastasize in very rare cases. 
Disease 
Epithelioid haemangioendothelioma 
Epidemiology 
Extremely rare 
Clinics 
Pain and swelling but sometimes asymptomatic. 
Cytogenetics 
WWTR1-CAMTA1 and YAP1-TFE3 fusions 
(t(1;3)(p36;q25) WWTR1/CAMTA1 and 
t(X;11)(p11;q22) YAP1/TFE3). 
Prognosis 
Involvement of two bones is associated with a worse 
prognosis regardless of the number of organs 
involved. 
Disease 
Angiosarcoma 
Epidemiology 
Extremely rare. 
Clinics 
In general, presents as a painful mass. Depending on 
the size and localization of the tumor, neurological 
deficit or other symptoms can occur. 
Cytogenetics 
No cytogenetic investigations of angiosarcoma in 
bone are reported. 
Genes 
PTPRB, PLCG1, CIC, KDR, and FLT4 mutations 
and MYC amplifications. 
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